JPM 2022: Amgen dials up biosimilar ambitions, with at least $4B in expected sales by 2030 fkansteiner Tue, […]

JPM 2022: Sanofi has designs on creating Big Pharma’s ‘strongest’ immunology franchise, CFO says esagonowsky Tue, 01/11/2022 – […]

JPM 2022: AbbVie adjusts 2025 individual sales projections for Rinvoq and Skyrizi but not their combined total of […]

Researchers at Uppsala University have used AI to develop a new method to study brain cancer. The method […]

At the first sign of cognitive trouble, people often worry Alzheimer’s disease is forthcoming. But poor cognition can […]

Two people who had serious diseases but not terminal prognoses have ended their lives legally in Colombia with […]

A research team has successfully repurposed an approved drug ifenprodil, a vasodilator, to be used in combination with […]

JPM22, Day 2: Teva’s opioid litigation, Roche’s Tecentriq ambitions and more esagonowsky Tue, 01/11/2022 – 08:17

JPM 2022: Bluebird CEO sees ‘unfinished business’ with Zynteglo in Europe, but scale-up needed first aarmstrong Tue, 01/11/2022 […]

JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022 fkansteiner Tue, 01/11/2022 – 09:31